Jianxin Xue

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 537 citations

Life Sciences, Biotechnology, Oncology +14

Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)

Caicun Zhou, Caicun Zhou, Lin Wu et al. · Journal of Thoracic Oncology · 2021 · 317 citations · Full text

Medicine, Oncology, Pharmacology +8

Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer

Limei Yin, Jianxin Xue, Rui Li et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 140 citations

Medicine, Oncology, Radiation Oncology +17

KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming

Feifei Na, Xiangyu Pan, Jingyao Chen et al. · Nature Cancer · 2022 · 120 citations · Full text

Medicine, Molecular Biology, Oncology +14

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

Wenhao Guo, Yu Zhang, Ting Chen et al. · Journal of Cancer Research and Clinical Oncology · 2010 · 97 citations · Full text

Medicine, Molecular Biology, Oncology +9